Wafergen To Locate First Foreign Plant In India
This article was originally published in PharmAsia News
Wafergen Biosystems of California plans to locate its first foreign plant for producing stem cells in India. Wafergen CEO Alnoor Shivji said the deal means his company can use the plant to focus on activities at the pre-production stage of smart-chip development. The parent company plans to operate through its Malaysian subsidiary, Wafergen Biosystems Malaysia. (Click here for more
You may also be interested in...
Novartis seems to have accepted the fact that the indication granted for Piqray in the EU means there is little scope for the advanced breast cancer drug to be used in markets such as the UK.
Generic OTC paracetamol and ibuprofen pack prices are gradually returning to pre-COVID levels, according to market analysts Wavedata. But a second wave could drive prices back up again.
Latest EU company news: Sanofi grows OTC portfolio in France and Italy with ColdZyme; Germany's WindStar Medical gets UK owners; and France's Ipsen continues to fell effects of COVID-19 on sales.